Regulatory News:
Aptorum Group Limited announced today that following a comprehensive review of the trading volume, costs and administrative requirements related to its listing on Euronext Paris,. | June 10, 2023
Regulatory News:
Aptorum Group Limited , a clinical stage biopharmaceutical company dedicated to meeting unmet medical needs in oncology, autoimmune diseases and infectious diseases, today. | May 5, 2023
Regulatory News: Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) ("Aptorum Group" or "Aptorum"), a clinical stage biopharmaceutical company dedicated to meeting unmet medical needs in oncology
Aptorum Group Receives Nasdaq Notification of Minimum Stockholders' Equity Deficiency streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.